If you haven’t had time to catch-up on all the methods papers published in the last couple of months, here’s our take on the most important covering all aspects of HTA.
Higgins J, Altman D, Gøtzsche P, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011; 343 doi: 10.1136/bmj.d5928 (Published 18 October 2011)
Dolan P. Thinking about it: thoughts about health and valuing QALYs. Health Economics, Article first published online: 22 OCT 2010 | DOI: 10.1002/hec.1679
Ring N, Jepson R, Ritchie K. Methods of synthesizing qualitative research studies for health technology assessment. International Journal of Technology Assessment in Health Care / Volume 27 / Issue 04, pp 384 - 390
Pullenayegum E, Tarride J, Xie F et al. Calculating Utility Decrements Associated With an Adverse Event: Marginal Tobit and CLAD Coefficients Should Be Used With Caution Med Decis Making November/December 2011 31: 790-799, doi:10.1177/0272989X11393284
Sullivan P, Slejko J, Sculpher M, et al. Catalogue of EQ-5D Scores for the United Kingdom. Med Decis Making November/December 2011 31: 800-804, first published on March 21, 2011 doi:10.1177/0272989X11401031
Lung T, Hayes A, Hayen A, et al. A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation. Quality of Life Research Volume 20, Number 10 / December 2011, pp1669-1678.
Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research Volume 20, Number 10 / December 2011, pp1727-1736
Ades A, Mavranezouli I, Dias S, et al. Network Meta-Analysis with Competing Risk Outcomes. Value in Health, Article first published online: 3 SEP 2010 | DOI: 10.1111/j.1524-4733.2010.00784.x
